COMP <GO>
PRTA vs ASMB // RETURN ON INVESTED CAPITAL (ROIC)
Prothena Corporation plc (NASDAQ) VS. Assembly Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: PRTA 2
— ASMB 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ASMB
LAST: $8.88 (-2.42%) • MKT CAP: $455.9M
roic
-35.00%
LAST: $20.86 (+1.41%) • MKT CAP: $424.7M
roic
-6.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRTA VS. ASMB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRTA | ASMB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | -6.50% | -28.50 | ASMB | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -9.69% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -16.80% | -43.20 | ASMB | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -8.50% | -51.50 | ASMB | /net-margins <GO> |
| Revenue Growth (YoY) | -65.00% | 153.50% | -218.50 | ASMB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 1.57 | -1.37 | ASMB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | ASMB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.4 | 35.9 | +12.54 | PRTA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $455.9M | $424.7M | $31.2M | PRTA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRTA REV | ASMB REV | PRTA GROSS % | ASMB GROSS % | PRTA FCF | ASMB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.7M | $72.3M | — | — | -$163.6M | -$41.2M |
| FY 2024 | $135.2M | $28.5M | — | — | -$150.1M | -$51.1M |
| FY 2023 | $91.4M | $0 | — | — | -$133.9M | $22.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRTA // BETA —
ASMB // BETA —